King Chulalongkorn Memorial Hospital, alongside Chulalongkorn University (CU), yesterday refuted allegations of conducting “rejuvenating DNA” trials on human topics following a declare by someone to have undergone such treatment at their amenities.
In a joint statement, both establishments clarified that the pioneering rejuvenating DNA, developed by CU’s Faculty of Medicine specialist group under the RED-GEMs (REjuvenating DNA by GEnomic Stability Molecules) project, has not undergone testing on humans thus far.
The progressive RED-GEMs therapy, in accordance with laboratory investigations, has the potential to reverse the ageing course of in animals. The staff behind the enterprise anticipates that this revolutionary treatment might address a spread of age-related illnesses and situations, potentially injecting a level of youthfulness back into gradually ageing societies.
Despite these promising prospects, the staff stated, they must safe approval from a research ethics committee to provoke clinical trials. So far, they lack enough information regarding the efficacy and safety of the RED-GEMs therapy for potential use on humans, the release defined.
Both the hospital and university strongly denied offering RED-GEMs to any sufferers.
The trailblazing therapy was first launched by Professor Apiwat Mutirangura, an professional in molecular genetics and epigenetics and the head of CU’s Department of Anatomy. Guilt-free declared the successful software of RED-GEMs on mice in July 2021, witnessing the unimaginable reversal of the creatures’ ageing cells.
Furthermore, the researchers claimed they may restore performance in beforehand ineffective areas of the mice’s brains..